Report - TRILACICLIB, A CDK4/6 INHIBITOR, DOES NOT IMPAIR THE EFFICACY OF ... - G1 … · 2018-12-05 · CONCLUSIONS • Trilaciclib, a highly potent, selective, and reversible CDK4/6 inhibitor,

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form